Greg Bannish received his PhD in immunology studying combined immunodeficiency, and performed postdoctoral studies at UPENN studying B cell receptor signaling. He then moved to Janssen (formerly Centocor), where he developed assays for immunological targets and improved hybridoma generation. Then he moved to Envigo for 11 years, developing a flow cytometry, cell culture, and immunology laboratory operating under GxP regulations, and later as Vice President, biopharmaceutical research, responsible for US biological drug programs. He then moved to Champions Oncology for 3 years to create, run, and support a regulatory flow cytometry laboratory. Recently, Greg has joined Flowmetric, Inc. as Senior Director of Laboratory Operations, where he is responsible to grow and support global flow cytometry operations.
FlowMetric Life Sciences, Inc.
4 Spring House Innovation Park
727 Norristown Road
Building 4 – Suite 200
Spring House, PA 19002
(267) 893-6630
FlowMetric Europe, S.p.A.
Via Ariosto, 21
20091 Bresso (MI)
VAT n: 08741490968
Italy
+39 02 89950272
Mail: info-europe@flowmetric.com
Certified mail: flowmetriceuropesrl@legalmail.it
Copyright ©2023 FlowMetric
Privacy Policy
STAY CONNECTED